1887

n South African Pharmaceutical and Cosmetic Review - Eli Lilly commits to funding for MDR-TB : communicable diseases

USD

 

Abstract

Eli Lilly has been pivotal in funding research into multi-drug resistant tuberculosis and increasing awareness. This year it has committed to enabling others to assist in overcoming this disease.

Loading

Article metrics loading...

/content/im_sapcr/39/2/EJC41728
2012-02-01
2016-12-05
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error